(Q43650700)

25 November 2017

title

Quinolone resistance in neutropenic patients: the effect of prescribing policy in the UK and Pakistan (English)

1 reference

25 November 2017

0 references

1 reference

Y Zaidi

1

1 reference

25 November 2017

M Hastings

2

1 reference

25 November 2017

J Murray

3

1 reference

25 November 2017

R Hassan

4

1 reference

25 November 2017

M Kurshid

5

1 reference

25 November 2017

P Mahendra

6

1 reference

25 November 2017

publication date

1 February 2001

1 reference

International Journal of Laboratory Hematology

25 November 2017

published in

1 reference

25 November 2017

volume

23

1 reference

25 November 2017

issue

1

1 reference

25 November 2017

page(s)

39-42

1 reference

Emergence of quinolone-resistant Escherichia coli bacteremia in neutropenic patients with cancer who have received prophylactic norfloxacin.

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00347.X

Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00347.X

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Tre

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00347.X

Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00347.X

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00347.X

Double-blind randomized study of prophylactic trimethoprim/sulfamethoxazole in granulocytopenic patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00347.X

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00347.X

Trimethoprim/sulfamethoxazole prophylaxis in neutropenic patients. Reduction of infections and effect on bacterial and fungal flora.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00347.X

Oral antibiotic prophylaxis in patients with cancer: A double-blind randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.2001.00347.X

10.1046/J.1365-2257.2001.00347.X

21 January 2018

Identifiers

DOI

1 reference

25 November 2017

1 reference